Accelerating Implementation of Long-Acting Injectables
RWHAP Technical Assistance Provider updated on 03/06/2024
RWHAP Technical Assistance Provider updated on 03/06/2024
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource updated 10/11/2023
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Preliminary results from an ongoing RWHAP clinic initiative to use text messaging as a re-engagement strategy to bring lost patients back to care, which may be a more manageable and possibly equally effective re-engagement strategy when compared to phone outreach.
Resource (Conference Presentation) updated 09/14/2023
The COVID-19 pandemic propelled digital tools to the forefront of healthcare. New York State Department of Health AIDS Institute Digital Health Initiative (DHI) coordinated digital health trainings to enhance practices among HIV program staff and may result in improved patient-provider communication, patient access to services and potentially health outcomes.
Resource (Conference Presentation) updated 09/14/2023
Enhancement of communication between Chicago HIV patients and case managers through use of smart phones and its particular value during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
Positive People social platform developed to expand access to the broader community and improve health outcomes for participants.
Resource (Conference Presentation) updated 09/14/2023
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 03/19/2024
Resource updated 03/13/2024
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
Healthcare providers can receive no-cost expert clinical consultation in HIV prevention & care, HCV treatment, and substance use management.
Resource updated 09/20/2023
Federal guidelines for treatment, prevention and care of HIV disease, opportunistic infections, and common co-infections.
Resource updated 09/19/2023
CPAPA is no longer being updated by NASTAD and has been replaced by Pharmaceutical Company Patient Assistance Programs and Cost-Sharing Assistance Programs.
Resource updated 10/31/2023
Curriculum on how to replicate models of care developed to engage and retain hard-to-reach populations into HIV medical care. Document can also serve as a quality improvement tool.
Resource updated 03/13/2024